Alternatives

Is private real estate underestimating risk for US life sciences? 

President Donald Trump’s One Big Beautiful Bill Act will create additional headwinds for an already challenged sector.

Alternative real estate sectors ride a wave of investor interest

What was once viewed as a ‘nuts’ strategy is now accounting for a growing share of fundraising and transaction activity.

Fifth Wall’s Wallace: The unicorn is back – but only the strong survive

Today’s billion-dollar proptech companies are not built on vanity metrics or market froth. They are grounded in traction, durability and purpose, writes Brendan Wallace, CEO and chief investment officer at Fifth Wall.

AXA IM Alts’ Scemama: Macro forces reinforce interest in real assets

The importance of asset management has remained constant in a changing world, writes Isabelle Scemama, global head of AXA IM Alts.

Macquarie recruits Ventas, Harrison Street execs to launch $5bn US senior housing platform

The Sydney-based manager’s new subsidiary Health Wave Partners will invest in core-plus properties across the US.

Even for Blackstone, privatizations are not a sure bet

Two UK take-privates failed to take off this week, leaving big-name private equity firms facing an increasingly competitive market for listed buying opportunities in real estate.

Tony Ressler, Howard Marks back Tryperion’s fourth fund

TREF IV raised $163m and is over 70% deployed.

Royal London makes senior hires in £1bn healthcare RE push

UK insurer’s deployment plans in the sector are part of a larger goal to allocate around 30% of its property portfolio to alternatives.

Realterm reels in €470m for second European IOS fund

The Maryland-based logistics specialist’s latest capital haul is nearly five times the size of its inaugural pan-European vehicle from 2020.